Sort
15,440 grants matching “organoids”
Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease
$877,246Scott Allen Noggle · New York Stem Cell Foundation · R01 · FY2019 · AG
Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease
$877,246Scott Allen Noggle · New York Stem Cell Foundation · R01 · FY2020 · AG
Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease
$877,246Valentina Fossati · New York Stem Cell Foundation · R01 · FY2022 · AG
Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease
$877,246Scott Allen Noggle · New York Stem Cell Foundation · R01 · FY2021 · AG
Spectinomycin analogs for NTM infections
$877,232Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2020 · AI
Compound repositioning for Alzheimer's Disease using knowledge graphs, insurance claims data, and gene expression complementarity
$877,205Andrew I Su · Scripps Research Institute, The · R01 · FY2024 · AG
Modeling KRAS-Dependent Synthetic Lethality in Human Colon Organoids
$876,328Calvin J Kuo · Stanford University · U01 · FY2018 · CA
Pro-Electrophilic Drugs PEDs for Alzheimer's Disease
$876,156Stuart A Lipton · Scripps Research Institute, The · R56 · FY2021 · AG
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer
$875,957Mary Christine Playdon · Utah State Higher Education System--University Of Utah · U01 · FY2025 · CA
Understanding Mechanisms and Sex-Differences in Visceral Pain
$875,653Holly A. Ingraham · University Of California, San Francisco · R01 · FY2023 · DK
A microengineered colon cancer-chip designed to investigate tumor-stromal interactions driving cancer progression
$875,151Shannon Michelle Mumenthaler · University Of Southern California · R01 · FY2021 · CA
Effects of inflammaging on intestinal epithelial cells and aspirin chemoprevention.
$874,747Andrew T Chan · Massachusetts General Hospital · R01 · FY2024 · CA
Biomarkers and mechanisms in cancer associated thrombosis
$874,736Jeffrey Zwicker · Beth Israel Deaconess Medical Center · U01 · FY2020 · HL
Biomarkers and mechanisms in cancer associated thrombosis
$874,736Jeffrey Zwicker · Beth Israel Deaconess Medical Center · U01 · FY2021 · HL
Biomarkers and mechanisms in cancer associated thrombosis
$874,736Jeffrey Zwicker · Beth Israel Deaconess Medical Center · U01 · FY2019 · HL
An Integrated Drug Discovery Platform for Neurodevelopmental Disorders Using Standardized Self-Organizing Human Cerebroids
$873,768Fred Etoc · Rumi Scientific, Inc. · R44 · FY2025 · MH
Resolving complex alternative splicing of psychiatric disease genes using single-cell approaches
$872,931Gang Fang · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · MH
Mechanisms underlying gastric intestinal metaplasia and carcinogenesis
$872,392Anil K Rustgi · Columbia University Health Sciences · R01 · FY2024 · CA
Studying factors controlling cancer progression and immune recognition in mouse models
$871,800Tyler E Jacks · Massachusetts Institute Of Technology · R35 · FY2022 · CA
Organ specific microenvironmental regulation of metastasis
$871,771Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Pediatric Kidney Single Cell Atlas Project
$871,642Sanjay Jain · Washington University · P50 · FY2022 · DK
Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids
$871,147Pietro P Sanna · Scripps Research Institute, The · R01 · FY2021 · DA
Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids
$871,147Pietro P Sanna · Scripps Research Institute, The · R01 · FY2022 · DA
The Role of Stem Cells and the Microenvironment in Gastrointestinal Cancers
$871,044Timothy Cragin Wang · Columbia University Health Sciences · R35 · FY2021 · CA
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
$871,023William Laurence Dahut · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA